|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
12 December 2020 |
|
Main ID: |
NCT02661841 |
|
Date of registration:
|
20/01/2016 |
|
Prospective Registration:
|
Yes |
|
Primary sponsor: |
|
|
Public title:
|
Effectiveness of Lung Impedance Guided Preemptive Therapy of Chronic Heart Failure Patients With Preserved Ejection Fraction (LVEF = 45%) in Our Hospital's Outpatient Clinic
|
|
Scientific title:
|
Effectiveness of Lung Impedance Guided Preemptive Therapy of Chronic Heart Failure Patients With Preserved Ejection Fraction (LVEF = 45%) in Our Hospital's Outpatient Clinic |
|
Date of first enrolment:
|
February 1, 2016 |
|
Target sample size:
|
300 |
|
Recruitment status: |
Recruiting |
|
URL:
|
https://clinicaltrials.gov/show/NCT02661841 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Single (Participant).
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
Israel
| | | | | | | |
|
Contacts
|
|
Name:
|
Michael Shochat, MD, PhD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Hillel Yaffe Medical Center |
|
|
Name:
|
Michael Shochat, MD, PhD |
|
Address:
|
|
|
Telephone:
|
972-4-630-4491 |
|
Email:
|
shochat@gmail.com |
|
Affiliation:
|
|
|
|
Name:
|
Michael Shochat, MD, PhD |
|
Address:
|
|
|
Telephone:
|
972-4-630-4491 |
|
Email:
|
shochat1@gmail.com |
|
Affiliation:
|
|
|
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Patients hospitalized within past 12 months for heart failure
Exclusion Criteria:
- Dialysis patients
- Patients with GFR <25
- Patients with serious illness and life expectancy <12
- Mentally incompetent
Age minimum:
18 Years
Age maximum:
N/A
Gender:
All
|
|
Health Condition(s) or Problem(s) studied
|
|
Heart Failure
|
|
Intervention(s)
|
|
Other: Heart Failure Guidelines
|
|
Other: LI-Guided Therapy
|
|
Primary Outcome(s)
|
|
Reduced mortality
[Time Frame: Five years]
|
|
Reduced all cause, cardiovascular, and heart failure hospitalizations
[Time Frame: Five years]
|
|
Secondary ID(s)
|
|
0086-15 HYMC
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|